Summary
- Current Price
- As of today, CANF price is $4.60, down -23.59% on
- Current Price All-Time High
- CANF price is currently -99.98% below its historical high of $28,380.00 set on
- Market Cap
- CANF current market cap is $6M, down -62.62% year-over-year
- PE Ratio
- CANF PE ratio is unknown
- Revenue
- CANF current annual revenue is $677.20K, down -8.86% year-over-year
- Next Earnings
- As of today, the next earnings release for CANF has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Can-Fite BioPharma Ltd. |
| Ticker | NYSEAmerican: CANF |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | canfite.com |
| Employees | 5 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.60 | ||
| Price, 1D Change | -23.59% | |
| $6M | ||
| - | ||
| - | ||
| 0.40 | ||
| $677K | ||
| Revenue, 1Y Change | -8.86% | |
| -$3,273.46 | ||
| EPS, 1Y Change | -182,672.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3,273.46 | ||
| EPS Estimate | N/A | -$10.40 |
| EPS Est. Change | N/A | +99.68% |
| $677.20K | ||
| Revenue Estimate | N/A | $202.00K |
| Revenue Est. Change | N/A | -70.17% |
| $4.60 | ||
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +986.96% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.30 | -$1.79 | -37.77% | |
| - | -$3,273.46 | - | |
| -$10.40 | N/A | +99.68% | |
| -$0.72 | N/A | +99.98% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $690.00K | $743.00K | +7.68% | |
| $500.00K | $677.20K | +35.44% | |
| $202.00K | N/A | -70.17% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -85.80% | ||
| -91.51% | ||
| -62.62% | ||
| -37.22% | ||
| -8.86% | ||
| -20.61% | ||
| -182,672.93% | ||
| -39,592.77% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $4.60 | ||
| $11.44 | ||
| SMA 200 vs Price | +148.73% | |
| $4.35 | ||
| SMA 50 vs Price | -5.50% | |
| 0.40 | ||
| $0.78 | ||
| 50.64 | ||
| 168.98% | ||
| 89.46% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $677.20K | ||
| -$3,273.46 | ||
| $667.00K | ||
| 98.97% | ||
| -$8.13M | ||
| -1,206.23% | ||
| -$7.92M | ||
| -1,169.14% | ||
| -$8.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 4.38 | ||
| 4.38 | ||
| - | ||
| - | ||
| -26.51 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.44 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $5.44M | ||
| $7.89M | ||
| $9.12M | ||
| $8.98M | ||
| $3.68M | ||
| $2.05M | ||
| $104.00K | ||
| $53.00K | ||
| $618.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.55M | ||
| $8.80M | ||
| $7,000.00 | ||
| $0.00 | ||
| $7,000.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$7.64M | ||
| $1.50M | ||
| $6.71M | ||
| $5,000.00 | ||
| -$7.64M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CANF
FAQ
What is the ticker symbol for Can-Fite BioPharma Ltd.?
The ticker symbol for Can-Fite BioPharma Ltd. is NYSEAmerican:CANF
Does Can-Fite BioPharma Ltd. pay dividends?
No, Can-Fite BioPharma Ltd. does not pay dividends
What sector is Can-Fite BioPharma Ltd. in?
Can-Fite BioPharma Ltd. is in the Healthcare sector
What industry is Can-Fite BioPharma Ltd. in?
Can-Fite BioPharma Ltd. is in the Biotechnology industry
What country is Can-Fite BioPharma Ltd. based in?
Can-Fite BioPharma Ltd. is headquartered in Israel
When did Can-Fite BioPharma Ltd. go public?
Can-Fite BioPharma Ltd. initial public offering (IPO) was on November 6, 2012
Is Can-Fite BioPharma Ltd. in the S&P 500?
No, Can-Fite BioPharma Ltd. is not included in the S&P 500 index
Is Can-Fite BioPharma Ltd. in the NASDAQ 100?
No, Can-Fite BioPharma Ltd. is not included in the NASDAQ 100 index
Is Can-Fite BioPharma Ltd. in the Dow Jones?
No, Can-Fite BioPharma Ltd. is not included in the Dow Jones index
When was Can-Fite BioPharma Ltd. last earnings report?
Can-Fite BioPharma Ltd.'s most recent earnings report was on August 31, 2018
When does Can-Fite BioPharma Ltd. report earnings?
The date for Can-Fite BioPharma Ltd.'s next earnings report has not been announced yet
Data Sources & References
- CANF Official Website www.canfite.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1536196/000121390025031298/0001213900-25-031298-index.htm
- CANF Profile on Yahoo Finance finance.yahoo.com/quote/CANF
- CANF Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/canf